skip to navigation skip to search skip to content
industrial generation network

Activity

Industry Days: Additive Medicine - Medical silicone rubber in additive fabrication

Activity details
Day 26 May 2020  Download
Time 16:00 - 17:00 CEST
Type Webinar
Location Zoom

Share link


Recommend via emailRecommend

Recommendation of Industry Days: Additive Medicine - Medical silicone rubber in additive fabrication

Please sign in or register first.

Sign In / Register

Description

The Niedersächsische Zentrum für Biomedizintechnik und Implantatforschung (NIFE, Center for Biomedical Technology and Implant Research in Lower Saxony) is one of the world's leading locations for biomedical research and development.

Together with the Hearing4all Cluster of Excellence and the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) as well as other regional and national partners, an “Advanced Medicine Hub” was established. It covers a wide range of medical additive manufacturing - from the printing of tissue, partial organs and scaffolds to mechanical and active implants.

The combination of additive fabrication with digital processes and AI enables the implementation of personalized medicine. It requires new data management platforms that provide individual patient data and can be applied for the verification of personalized medical devices’ conformity processes. Combined with data pools, new, accelerated test procedures can be implemented.

What will participants learn from your webinar?
  • The importance of additive manufacturing for personalized medicine
  • New: 3D printing of medical silicone rubber in the manufacture of patient-specific implants
  • Additive medicine and MDR certification - an orientation
Why should you watch/participate?
  • We live in an increasingly dynamic world. Technological cycles are getting shorter and shorter, our lifestyles and needs are changing rapidly. What is required are innovative solutions that create value for everyone involved. The Fraunhofer ITEM develops solutions for this. With our mission statement, we set the course for a successful future. Here we define what we stand for, where we want to go and which values and principles we are guided by in order to master current and future challenges together. The Fraunhofer ITEM is one of about 70 institutes of the Fraunhofer-Gesellschaft, the largest organization for application-oriented research in Europe.
Who is the target group of this webinar?
  • Any company or organization involved in the additive manufacturing (of medical silicone harness) and addressing the challenge of patient-specific solutions and MDR certification.
Is advance registration required?
  • A registration would be important.

6 Professionals are joining

6 Professionals are joining

Contact

Speakers

<a href="https://www.industrial-generation.network/en/Theodor-Doll,a3145143">Theodor Doll</a>

Mr. Univ.-Prof. Dr.-Ing. habil Theodor Doll

Leiter des Leistungszentrums Translationale Medizintechnik

Company

Fraunhofer-Institut für Toxikologie und experimentelle Medizin (ITEM)

Fraunhofer-Institut für Toxikologie und experimentelle Medizin (ITEM)

Company

Company Profile

Fraunhofer ITEM aims to protect man from health hazards in our industrialized world and to contribute to the development of novel therapeutic approaches.
Focusing on lung and inhalation, Fraunhofer ITEM has pooled its expertise in three business units:
In the business unit Drug Development, we develop and test novel medications against respiratory diseases. Scientific expertise covers manufacturing of biologics, preclinical and clinical development.
The business unit Chemical Safety is dedicated to determining the risks from potentially harmful substances. Scientific expertise includes toxicology testing, exposure assessment, analytical methods, regulatory research and risk assessment.
The business unit Translational Biomedical Engineering offers many years of experience in the development of medical devices – specifically neuro-implants and medical aerosolizers – including testing and testing scenarios, safety and risk assessment.
All business units offer regulatory support. Numerous test systems are available, including in-vitro, ex-vivo and in-vivo. Studies can be performed in compliance with GXP regulations.
A Regensburg-based division is dedicated to personalized tumor therapy including development of diagnostic tests to enable early detection of disseminated cancer cells and prediction of the response to therapy of metastatic progenitor cells.
Fraunhofer ITEM is one of about 70 institutions of the Fraunhofer-Gesellschaft, Europe's leading organization for applied research.

Send an appointment request

Note: To make an appointment with a Professional, you need a Professional profile, which is visible online. You can create your profile here.

Please sign in or register first.

Sign In / Register

View company